Synopsys Shares Face Critical Earnings Test Amid Analyst Pivot
10.12.2025 - 09:05:04Synopsys US8716071076
The upcoming earnings report from Synopsys represents a pivotal moment for the semiconductor design software leader. Investors are watching closely as the company prepares to release its latest quarterly results after the US market closes today. This follows a period of significant volatility triggered by a substantial earnings miss last quarter. In a surprising pre-earnings development, several prominent analysts have shifted their stance on the stock, introducing a note of cautious optimism just hours before the figures are revealed.
Market apprehension is rooted in a recent disappointing performance. On September 9, Synopsys reported third-quarter results that fell dramatically short of Wall Street's projections, precipitating a steep decline in its share price. The stock lost over 30% in the subsequent months following that announcement.
The specifics of that quarterly miss were significant:
* Earnings Per Share (Q3): Reported $2.30 versus an expected $3.75
* Revenue (Q3): Reported $1.74 billion versus an expected $1.77 billion
This event eroded investor confidence, contributing to a year-to-date decline of approximately 15%. The shares currently trade near 399 euros, well below their 52-week high of over 565 euros.
A Surprising Pre-Earnings Analyst Shift
In an unusual move immediately preceding the earnings release, two major financial institutions revised their ratings. Rosenblatt Securities upgraded its view on Synopsys from "Neutral" to "Buy," although it concurrently reduced its price target from $605 to $560.
Should investors sell immediately? Or is it worth buying Synopsys?
Simultaneously, Bank of America (BofA) raised its rating from "Underperform" to "Neutral," also making a slight downward adjustment to its target price. The underlying message from these analysts suggests that the sharp valuation contraction in recent months may now present a compelling opportunity. They imply that the current share price adequately reflects the known risks, positioning it as an attractive entry point.
Stabilization and Strategic Focus
Consensus estimates for the report due tonight anticipate a stabilization in the business. Market experts project revenue of around $2.24 billion and earnings per share of $2.88. Meeting or exceeding these targets is viewed as crucial to validating the recent analyst upgrades.
Significant attention will also be directed toward the company's planned acquisition of Ansys. Investors are keenly focused on the projected combined backlog, estimated to be in the range of $9.3 to $9.5 billion. This metric is considered a key indicator of long-term demand strength in the electronic design automation (EDA) sector.
The market now waits to see if the company's results will justify the renewed analyst confidence. A report that meets expectations and provides reassuring guidance could signal a turning point. Conversely, another significant miss would likely extinguish the nascent hope for a sustained recovery.
Ad
Synopsys Stock: Buy or Sell?! New Synopsys Analysis from December 10 delivers the answer:
The latest Synopsys figures speak for themselves: Urgent action needed for Synopsys investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 10.
Synopsys: Buy or sell? Read more here...


